Effective management of advanced melanoma requires ACTIVATEd clinicians and patients working together. As treatment options continue to evolve, understanding how immune checkpoint inhibitors fit alongside other standard-of-care strategies is essential for developing individualized treatment plans.

This program supports shared decision-making by offering separate educational portals for clinicians and patients, providing each audience with the knowledge needed to better understand treatment options and align care with the goals of therapy for advanced melanoma.